Acuson of Mountain View, CA, announced that company president and director Daniel Dugan resigned effective March 1. Former Acuson president Robert Gallagher will come out of retirement to serve as president and chief operating officer until sometime in
Acuson of Mountain View, CA, announced that company president and director Daniel Dugan resigned effective March 1. Former Acuson president Robert Gallagher will come out of retirement to serve as president and chief operating officer until sometime in June, when a permanent replacement for Dugan will be named. Gallagher, 56, previously was president and chief operating officer.
Dugan, 45, has been with Acuson for many years. He held senior sales management positions with the company from 1984 to 1989, then returned in 1991 as vice president of field operations after spending two years at Toshiba America Medical Systems as vice president of U.S. ultrasound business operations. Dugan was made vice president of worldwide sales and field operations for Acuson in 1993, and senior vice president of worldwide sales, service, and marketing in March 1994. He was promoted to president in November 1997.
Dugans departure appears to be unrelated to the companys financial performance. In fact, the company is coming off its most successful year ever and record fourth-quarter revenues. The ultrasound vendor posted revenues of $135 million for the fourth quarter of 1999, an increase of 10% compared with the fourth quarter of 1998, and $475.9 million for the year, compared to $455 million in 1998. Excluding a one-time $13.9 million after-tax write-off associated with the December 1999 acquisition of Ecton, the company reported net income of $6.8 million in the fourth quarter of 1998. Including the write-off, Acuson reported a net loss for the quarter of $7.1 million.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.